The Gorlin Syndrome Group UK are proud to work in partnership with the Gorlin Syndrome Alliance in the USA, PellePharm and LEO Pharma to advance the development and research of new treatments for Gorlin Syndrome.
A video has been produced to promote the Patidegib trial. This topical gel will hopefully be a transformative BCC treatment option for people with Gorlin Syndrome.
The video will be shown at an upcoming European Academy of Dermatology and Venereology Conference in Madrid in October. If you are health care professional and interested in learning more, please stop by the PellePharm booth during EADV!
Any individual affected by Gorlin Syndrome who would like to consider enrolling for the trial can access information and contact details for sites in the UK For those wider afield in Europe kindly access the global study here